Results 191 to 200 of about 20,461 (225)
Some of the next articles are maybe not open access.
[Update on the diagnosis of HFrEF and HFpEF].
Deutsche medizinische Wochenschrift (1946), 2021Heart failure (HF) is the leading cause for inpatient treatment in Germany. Its diagnosis is based on the ESC Guidelines for Diagnosis and Treatment of Heart Failure of 2016. More than half of all patients with HF suffer from HF with preserved ejection fraction (HFpEF), whose diagnosis is still challenging.
Stefanie M, Werhahn, Rolf, Wachter
openaire +1 more source
HFrEF pharmacological treatment: ivabradine
2018Ivabradine slows down the heart rate through a blockade of the funny current channels in the sinoatrial node cells. The efficacy of the drug was tested in a large outcome clinical trial in stable chronic heart failure with reduced ejection fraction, in sinus rhythm, on a contemporary background therapy including beta blockers.
openaire +2 more sources
Comparison Chart: Some Drugs for HFrEF
The Medical Letter on Drugs and TherapeuticsComparison Chart: Some Drugs for ...
openaire +2 more sources
Dapagliflozin — a breakthrough in the search for drugs to treat HFrEF
Nature Reviews Cardiology, 2019Results from the DAPA-HF trial demonstrate that dapagliflozin therapy is associated with lower risk of worsening heart failure or cardiovascular death than placebo, regardless of the presence or absence of diabetes.
openaire +2 more sources
Circulating neuregulin in HFpEF and HFrEF
2015RAPID FIRE 1 – ACUTE HEART FAILURE ...
Hage, C. +6 more
openaire +1 more source
Promising findings for cell therapy in HFrEF
Nature Reviews Cardiology, 2023openaire +2 more sources
Neue Therapiekonzepte der HfrEF
Kardiologie up2date, 2021Amr Abdin, Jan Wintrich, Michael Böhm
openaire +1 more source
Cine MRI characterizes HFpEF and HFrEF in post-capillary pulmonary hypertension
European Journal of Radiology, 2021James Carr, , Kai Lin
exaly